Israel Englander Oncocyte Corp Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.2 - $0.35 $27,389 - $47,931	-136,946 Reduced 28.85%	337,765 $77,000
Q1 2023 May 15, 2023	SELL	$0.2 - $0.49 $17,330 - $42,458	-86,650 Reduced 15.44%	474,711 $168,000
Q4 2022 Feb 14, 2023	SELL	$0.25 - $15.6 $40,006 - $2.5 Million	-160,025 Reduced 22.18%	561,361 $180,000
Q3 2022 Nov 14, 2022	SELL	$0.76 - $15.98 $208,835 - $4.39 Million	-274,783 Reduced 27.58%	721,386 $527,000
Q2 2022 Aug 15, 2022	BUY	$0.86 - $1.53 $856,705 - $1.52 Million	996,169 New	996,169 $896,000
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $162,223 - $317,394	-141,064 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $322,540 - $567,607	-158,108 Reduced 52.85%	141,064 $306,000
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $834,449 - $1.39 Million	-236,388 Reduced 44.14%	299,172 $1.07 Million
Q2 2021 Aug 16, 2021	SELL	$3.77 - $6.0 $185,551 - $295,308	-49,218 Reduced 8.42%	535,560 $3.07 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $1.26 Million - $3.43 Million	527,032 Added 912.67%	584,778 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $24,032 - $45,801	17,415 Added 43.18%	57,746 $138,000
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $48,397 - $76,225	40,331 New	40,331 $56,000
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $75,592 - $113,638	-50,061 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.59 - $2.51 $62,304 - $98,354	-39,185 Reduced 43.91%	50,061 $105,000
Q2 2019 Aug 15, 2019	BUY	$2.49 - $5.45 $138,110 - $302,289	55,466 Added 164.2%	89,246 $222,000
Q2 2019 Aug 14, 2019	SELL	$2.49 - $5.45 $484,932 - $1.06 Million	-194,752 Reduced 85.22%	33,780 $108,000
Q1 2019 May 14, 2019	BUY	$1.47 - $5.91 $335,942 - $1.35 Million	228,532 New	228,532 $903,000
Q4 2018 Feb 14, 2019	SELL	$1.38 - $2.59 $43,584 - $81,799	-31,583 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.2 - $3.45 $202,903 - $318,190	-92,229 Reduced 74.49%	31,583 $79,000
Q2 2018 Aug 14, 2018	BUY	$2.0 - $3.3 $247,624 - $408,579	123,812 New	123,812 $316,000

Others Institutions Holding OCX

# of Institutions

Shares Held

411K

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account